Murrayafoline A Induces a G0/G1-Phase Arrest in Platelet-Derived Growth Factor-Stimulated Vascular Smooth Muscle Cells

The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology
Joo-Hui HanChang-Seon Myung

Abstract

The increased potential for vascular smooth muscle cell (VSMC) growth is a key abnormality in the development of atherosclerosis and post-angioplasty restenosis. Abnormally high activity of platelet-derived growth factor (PDGF) is believed to play a central role in the etiology of these pathophysiological situations. Here, we investigated the anti-proliferative effects and possible mechanism(s) of murrayafoline A, a carbazole alkaloid isolated from Glycosmis stenocarpa Guillamin (Rutaceae), on PDGF-BB-stimulated VSMCs. Murrayafoline A inhibited the PDGF-BB-stimulated proliferation of VSMCs in a concentration-dependent manner, as measured using a non-radioactive colorimetric WST-1 assay and direct cell counting. Furthermore, murrayafoline A suppressed the PDGF-BB-stimulated progression through G0/G1 to S phase of the cell cycle, as measured by [(3)H]-thymidine incorporation assay and cell cycle progression analysis. This anti-proliferative action of murrayafoline A, arresting cell cycle progression at G0/G1 phase in PDGF-BB-stimulated VSMCs, was mediated via down-regulation of the expression of cyclin D1, cyclin E, cyclin-dependent kinase (CDK)2, CDK4, and proliferating cell nuclear antigen (PCNA), and the phosphorylation of ret...Continue Reading

References

Sep 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·T AkiyamaK Toyoshima
Jan 1, 1995·Annual Review of Physiology·R Ross
Jan 1, 1993·British Heart Journal·E W Raines, R Ross
Apr 15, 1997·Annals of the New York Academy of Sciences·Y YoshidaQ Shu
Sep 18, 1998·Biochimica Et Biophysica Acta·C H HeldinL Rönnstrand
Jun 19, 2001·Proceedings of the National Academy of Sciences of the United States of America·T BowmanR Jove
May 11, 2002·American Journal of Physiology. Lung Cellular and Molecular Physiology·Amy R SimonBrent H Cochran
Nov 2, 2002·Nature Medicine·Victor J DzauDaniel G Sedding
Mar 16, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Ruediger C Braun-DullaeusVictor J Dzau
Oct 7, 2004·Chemical & Pharmaceutical Bulletin·Nguyen Manh CuongWalter Chacles Taylor
Feb 13, 2008·Developmental Cell·Arnaud BessonJames M Roberts
Nov 22, 2008·Natural Product Research·N M CuongL Wessjohann
Nov 3, 2010·European Journal of Pharmacology·Jung-Jin LeeYeo-Pyo Yun
Oct 16, 2012·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Safaa Yehia EidMichael Wink

❮ Previous
Next ❯

Methods Mentioned

BETA
percutaneous transluminal coronary angioplasty

Software Mentioned

GraphPad
ModFit LT

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.